HLB Genex

At a glance

HLB Genex filed 66 disclosures in the last 12 months, including 18 insider and 17 5% holder. The most recent key filing was on Oct 15: A major holder's stake rose from 38.55% to 39.10% (open-market buy).

Revenue for 2025 was ₩43.4B, up 22.4% on 2024. Operating margin was 2.8% against -5.3% a year earlier. Debt was 148% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩23B and operating profit of ₩2B.

The 2025 annual report lists 82 employees with an average tenure of 6 years and average pay of ₩57.5M, #1296 of 2,191 listed companies by average pay. Its 9 directors and auditors were paid ₩77.7M each on average. It paid no cash dividend for 2025. 에이치엘비(주) and related parties held 31.32% at year end.

Of 5 recent 5%+ holder reports, 3 raised and 1 cut a stake; the largest stake reported was 39.10% on Oct 15.

From the 2025 annual report

Staff: 82 (49 men, 33 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩4.7B. Directors and auditors: 9, paid ₩699.4M in total.

No cash dividend was paid for 2025.

Largest shareholder

에이치엘비(주) holds 8.95%; with 9 related parties the group holds 31.32% of common shares at year end (from 30.74% at the start of the year).

Auditor: 삼도회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

5%+ holder reports